Skip to main content
Top
Published in: Nutrition & Metabolism 1/2011

Open Access 01-12-2011 | Research

Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study

Authors: Yukiyoshi Okauchi, Ken Kishida, Tohru Funahashi, Midori Noguchi, Tomoko Ogawa, Kohei Okita, Hiromi Iwahashi, Tetsuya Ohira, Akihisa Imagawa, Tadashi Nakamura, Iichiro Shimomura

Published in: Nutrition & Metabolism | Issue 1/2011

Login to get access

Abstract

Background

Circulating thiobarbituric acid-reacting substance (TBARS) levels, a marker of systemic oxidative stress, are predictive of cardiovascular events. However, they has not been evaluated in Japanese, especially with regard to the factors that contribute to the changes in circulating TBARS levels. We investigated the cross-sectional and longitudinal relationships between circulating TBARS levels and various clinicobiochemical parameters in middle-aged men.

Methods

In this population-based study (The Amagasaki Visceral Fat Study), 1,178 Japanese male urban workers who had undergone health check-ups in 2006, 2007 and 2008 and were not on medications for metabolic disorders during the follow-up period, were enrolled. Serum TBARS levels were measured by the method of Yagi. The estimated visceral fat area (eVFA) by bioelectrical impedance was measured annually. After health check-ups, subjects received health education with lifestyle modification by medical personnel.

Results

The number of cardiovascular risk factors (hypertension, hyperglycemia, low HDL-C, hypertriglyceridemia, hyperuricemia, hyper-LDL-C and impaired renal function) augmented with the increases in log-eVFA (p < 0.0001) and log-TBARS (p < 0.0001). The combination of TBARS and eVFA had a multiplicative effect on risk factor accumulation (F value = 79.1, p = 0.0065). Stepwise multiple regression analysis identified log-eVFA, as well as age, log-body mass index (BMI), LDL-C, log-adiponectin, γ-glutamyl transpeptidase (γ-GTP) and uric acid as significant determinants of log-TBARS. Stepwise multiple regression analysis identified one-year changes in eVFA as well as BMI, γ-GTP and estimated glomerular filtration rate (eGFR) as significant determinants of one-year change in TBARS, and biennial changes in eVFA as well as BMI and γ-GTP, eGFR as significant determinants of biennial change in TBARS.

Conclusions

The present study showed a significant cross-sectional and longitudinal correlation between TBARS and eVFA, as well as BMI and γ- GTP, eGFR. Visceral fat reduction may independently associate with the improvement in systemic ROS in middle-aged Japanese men.

Trial Registration

The Amagasaki Visceral Fat Study UMIN000002391.
Appendix
Available only for authorised users
Literature
1.
go back to reference Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella AM, Armstrong D: Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001, 154: 348-356. 10.1093/aje/154.4.348CrossRef Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella AM, Armstrong D: Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001, 154: 348-356. 10.1093/aje/154.4.348CrossRef
2.
go back to reference Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38: 263-355. 10.1080/20014091084227CrossRef Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38: 263-355. 10.1080/20014091084227CrossRef
3.
go back to reference Corry DB, Tuck ML: Uric acid and the vasculature. Curr Hypertens Rep 2006, 8: 116-119. 10.1007/s11906-006-0006-yCrossRef Corry DB, Tuck ML: Uric acid and the vasculature. Curr Hypertens Rep 2006, 8: 116-119. 10.1007/s11906-006-0006-yCrossRef
4.
go back to reference Schisterman EF, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P, Armstrong D, Reiser B, Trevisan M: TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk 2001, 8: 219-225. 10.1097/00043798-200108000-00006CrossRef Schisterman EF, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P, Armstrong D, Reiser B, Trevisan M: TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk 2001, 8: 219-225. 10.1097/00043798-200108000-00006CrossRef
5.
go back to reference Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP, PREVENT study: Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 2004, 44: 1996-2002. 10.1016/j.jacc.2004.08.029CrossRef Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP, PREVENT study: Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 2004, 44: 1996-2002. 10.1016/j.jacc.2004.08.029CrossRef
6.
go back to reference Tanaka SI, Miki T, Sha S, Hirata KI, Ishikawa Y, Yokoyama M: Serum Levels of Thiobarbituric Acid-Reactive Substances are Associated with Risk of Coronary Heart Disease. J Atheroscler Thromb 2011, 18: 584-591. 10.5551/jat.6585CrossRef Tanaka SI, Miki T, Sha S, Hirata KI, Ishikawa Y, Yokoyama M: Serum Levels of Thiobarbituric Acid-Reactive Substances are Associated with Risk of Coronary Heart Disease. J Atheroscler Thromb 2011, 18: 584-591. 10.5551/jat.6585CrossRef
7.
go back to reference Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114: 1752-1761.CrossRef Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114: 1752-1761.CrossRef
8.
go back to reference Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440: 944-948. 10.1038/nature04634CrossRef Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440: 944-948. 10.1038/nature04634CrossRef
9.
go back to reference Ryo M, Nakamura T, Funahashi T, Noguchi M, Kishida K, Okauchi Y, Nishizawa H, Ogawa T, Kojima S, Ohira T, Okita K, Iwahashi H, Imagawa A, Matsuzawa Y, Shimomura I: Health education program reduced prevalence of the metabolic syndrome in the Amagasaki Visceral Fat Study. Three year follow up study of 3,174 Japanese employees. Intern Med 2011, 50: 1643-1648. 10.2169/internalmedicine.50.5039CrossRef Ryo M, Nakamura T, Funahashi T, Noguchi M, Kishida K, Okauchi Y, Nishizawa H, Ogawa T, Kojima S, Ohira T, Okita K, Iwahashi H, Imagawa A, Matsuzawa Y, Shimomura I: Health education program reduced prevalence of the metabolic syndrome in the Amagasaki Visceral Fat Study. Three year follow up study of 3,174 Japanese employees. Intern Med 2011, 50: 1643-1648. 10.2169/internalmedicine.50.5039CrossRef
10.
go back to reference Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, Ryo M, Kihara S, Iwahashi H, Yamagata K, Nakamura T, Shimomura I, Matsuzawa Y: Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 2007, 30: 2392-2394. 10.2337/dc07-0218CrossRef Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, Ryo M, Kihara S, Iwahashi H, Yamagata K, Nakamura T, Shimomura I, Matsuzawa Y: Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 2007, 30: 2392-2394. 10.2337/dc07-0218CrossRef
11.
go back to reference Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 2009, 32: e122. 10.2337/dc09-1130CrossRef Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 2009, 32: e122. 10.2337/dc09-1130CrossRef
12.
go back to reference Okauchi Y, Kishida K, Funahashi T, Noguchi M, Morita S, Ogawa T, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis 2010, 212: 698-700. 10.1016/j.atherosclerosis.2010.06.011CrossRef Okauchi Y, Kishida K, Funahashi T, Noguchi M, Morita S, Ogawa T, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis 2010, 212: 698-700. 10.1016/j.atherosclerosis.2010.06.011CrossRef
13.
go back to reference Kishida K, Funahashi T, Shimomura I: Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective. Nutr Metab (Lond) 2011, 8: 57. 10.1186/1743-7075-8-57CrossRef Kishida K, Funahashi T, Shimomura I: Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective. Nutr Metab (Lond) 2011, 8: 57. 10.1186/1743-7075-8-57CrossRef
14.
go back to reference Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, Yamaguchi T, Funahashi T, Matsuzawa Y, Nakamura T, Shimomura I: A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care 2005, 28: 451-453. 10.2337/diacare.28.2.451CrossRef Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, Yamaguchi T, Funahashi T, Matsuzawa Y, Nakamura T, Shimomura I: A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care 2005, 28: 451-453. 10.2337/diacare.28.2.451CrossRef
15.
go back to reference Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976, 15: 212-216. 10.1016/0006-2944(76)90049-1CrossRef Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976, 15: 212-216. 10.1016/0006-2944(76)90049-1CrossRef
16.
go back to reference Nakatsuji H, Kishida K, Funahashi T, Shimomura I, Senri Study II Group: Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Atherosclerosis 2010, 212: 243-245. 10.1016/j.atherosclerosis.2010.05.025CrossRef Nakatsuji H, Kishida K, Funahashi T, Shimomura I, Senri Study II Group: Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Atherosclerosis 2010, 212: 243-245. 10.1016/j.atherosclerosis.2010.05.025CrossRef
17.
go back to reference Nakatsuji H, Kishida K, Kitamura T, Nakajima C, Funahashi T, Shimomura I: Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity. Metabolism 2010, 59: 520-526. 10.1016/j.metabol.2009.08.013CrossRef Nakatsuji H, Kishida K, Kitamura T, Nakajima C, Funahashi T, Shimomura I: Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity. Metabolism 2010, 59: 520-526. 10.1016/j.metabol.2009.08.013CrossRef
18.
go back to reference Armstrong D, Browne R: The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994, 366: 43-58. 10.1007/978-1-4615-1833-4_4CrossRef Armstrong D, Browne R: The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994, 366: 43-58. 10.1007/978-1-4615-1833-4_4CrossRef
19.
go back to reference Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. J Atheroscler Thromb 2010, 17: 1237-1245. 10.5551/jat.5694CrossRef Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I: Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. J Atheroscler Thromb 2010, 17: 1237-1245. 10.5551/jat.5694CrossRef
20.
go back to reference Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New Criteria for 'Obesity Disease' in Japan. Circ J 2002, 66: 987-992. 10.1253/circj.66.987CrossRef Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New Criteria for 'Obesity Disease' in Japan. Circ J 2002, 66: 987-992. 10.1253/circj.66.987CrossRef
21.
go back to reference Palmieri VO, Grattagliano I, Portincasa P, Palasciano G: Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr 2006, 136: 3022-3026. Palmieri VO, Grattagliano I, Portincasa P, Palasciano G: Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr 2006, 136: 3022-3026.
22.
go back to reference Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M: Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006, 70: 1437-1442. 10.1253/circj.70.1437CrossRef Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M: Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006, 70: 1437-1442. 10.1253/circj.70.1437CrossRef
23.
go back to reference Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38: 263-355. 10.1080/20014091084227CrossRef Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38: 263-355. 10.1080/20014091084227CrossRef
24.
go back to reference Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A: Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 2006, 40: 930-935. 10.1097/01.mcg.0000212608.59090.08CrossRef Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A: Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 2006, 40: 930-935. 10.1097/01.mcg.0000212608.59090.08CrossRef
25.
go back to reference Costa-Hong V, Bortolotto LA, Jorgetti V, Consolim-Colombo F, Krieger EM, Lima JJ: Oxidative stress and endothelial dysfunction in chronic kidney disease. Arq Bras Cardiol 2009, 92: 381-386. 398-403, 413-418CrossRef Costa-Hong V, Bortolotto LA, Jorgetti V, Consolim-Colombo F, Krieger EM, Lima JJ: Oxidative stress and endothelial dysfunction in chronic kidney disease. Arq Bras Cardiol 2009, 92: 381-386. 398-403, 413-418CrossRef
26.
go back to reference Kocak H, Gumuslu S, Ermis C, Mahsereci E, Sahin E, Gocmen AY, Ersoy F, Suleymanlar G, Yakupoglu G, Tuncer M: Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am J Nephrol 2008, 28: 91-96. 10.1159/000109397CrossRef Kocak H, Gumuslu S, Ermis C, Mahsereci E, Sahin E, Gocmen AY, Ersoy F, Suleymanlar G, Yakupoglu G, Tuncer M: Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am J Nephrol 2008, 28: 91-96. 10.1159/000109397CrossRef
27.
go back to reference Stinghen AE, Pecoits-Filho R: Vascular damage in kidney disease: beyond hypertension. Int J Hypertens 2011, 2011: 232683.CrossRef Stinghen AE, Pecoits-Filho R: Vascular damage in kidney disease: beyond hypertension. Int J Hypertens 2011, 2011: 232683.CrossRef
28.
go back to reference Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC: Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005, 38: 698-710. 10.1016/j.freeradbiomed.2004.09.017CrossRef Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC: Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005, 38: 698-710. 10.1016/j.freeradbiomed.2004.09.017CrossRef
Metadata
Title
Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study
Authors
Yukiyoshi Okauchi
Ken Kishida
Tohru Funahashi
Midori Noguchi
Tomoko Ogawa
Kohei Okita
Hiromi Iwahashi
Tetsuya Ohira
Akihisa Imagawa
Tadashi Nakamura
Iichiro Shimomura
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2011
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-8-82

Other articles of this Issue 1/2011

Nutrition & Metabolism 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine